BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14669040)

  • 1. Mantle cell lymphoma: established therapeutic options and future directions.
    Lenz G; Dreyling M; Hiddemann W
    Ann Hematol; 2004 Feb; 83(2):71-7. PubMed ID: 14669040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current strategies in the treatment of advanced stage mantle cell lymphoma].
    Lenz G; Dreyling M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of mantle cell lymphoma: current standards and future strategies.
    Schmidt C; Dreyling M
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):953-63, ix. PubMed ID: 18954745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?
    Dreyling M; Hiddemann W
    Curr Opin Oncol; 2008 Sep; 20(5):487-94. PubMed ID: 19106649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low-grade malignant non-Hodgkin lymphomas--current status and trends in therapy].
    Hiddemann W
    Ther Umsch; 1996 Feb; 53(2):123-32. PubMed ID: 8629262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell transplantation for mantle cell lymphoma: if, when and how?
    Kiss TL; Mollee P; Lazarus HM; Lipton JH
    Bone Marrow Transplant; 2005 Oct; 36(8):655-61. PubMed ID: 16007106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic advances for indolent lymphomas].
    Ogura M
    Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma.
    Thieblemont C; Antal D; Lacotte-Thierry L; Delwail V; Espinouse D; Michallet AS; Traulle C; Bouafia-Sauvy F; Giraud C; Salles G; Guilhot F; Coiffier B
    Cancer; 2005 Oct; 104(7):1434-41. PubMed ID: 16104036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells].
    Schüler F; Hirt C; Dölken L; Krüger W; Dölken G
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2130-4. PubMed ID: 16172952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of mantle cell lymphoma: current approach and future directions.
    Brody J; Advani R
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):257-65. PubMed ID: 16751087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.
    Andersen NS; Pedersen LB; Laurell A; Elonen E; Kolstad A; Boesen AM; Pedersen LM; Lauritzsen GF; Ekanger R; Nilsson-Ehle H; Nordström M; Fredén S; Jerkeman M; Eriksson M; Väärt J; Malmer B; Geisler CH
    J Clin Oncol; 2009 Sep; 27(26):4365-70. PubMed ID: 19652064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle cell lymphoma: advances in biology and therapy.
    Smith MR
    Curr Opin Hematol; 2008 Jul; 15(4):415-21. PubMed ID: 18536582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of mantle cell lymphoma].
    Dreyling M; Unterhalt M; Weigert O; Hiddemann W
    Internist (Berl); 2007 Apr; 48(4):382-8. PubMed ID: 17308912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of mantle cell lymphoma: targeting the microenvironment.
    Drach J; Seidl S; Kaufmann H
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):477-85. PubMed ID: 16001955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment approaches for mantle-cell lymphoma.
    Witzig TE
    J Clin Oncol; 2005 Sep; 23(26):6409-14. PubMed ID: 16155027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma.
    Lim SH; Esler WV; Periman PO; Beggs D; Zhang Y; Townsend M
    Br J Haematol; 2008 Jul; 142(3):482-4. PubMed ID: 18510683
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of overall survival in advanced stage mantle cell lymphoma.
    Herrmann A; Hoster E; Zwingers T; Brittinger G; Engelhard M; Meusers P; Reiser M; Forstpointner R; Metzner B; Peter N; Wörmann B; Trümper L; Pfreundschuh M; Einsele H; Hiddemann W; Unterhalt M; Dreyling M
    J Clin Oncol; 2009 Feb; 27(4):511-8. PubMed ID: 19075279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
    Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
    J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.